Urticarial Vasculitis After First Denosumab Injection in an Osteoporotic Woman Diagnosed with Cushing’s Syndrome
Denosumab is a human-derived monoclonal immunoglobulin G2 antibody against the receptor activator of nuclear factor kappa B ligand, inhibiting the differentiation and function of osteoclast precursor cells by its antiosteoclastic action. Denosumab is approved for postmenopausal, glucocorti coid-indu...
Spremljeno u:
| Glavni autori: | , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Society of Endocrinology and Metabolism of Turkey
2022-09-01
|
| Serija: | Endocrinology Research and Practice |
| Teme: | |
| Online pristup: | https://endocrinolrespract.org/index.php/pub/article/view/1123 |
| Oznake: |
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|